NASDAQ:SNWV Sanuwave Health (SNWV) Stock Price, News & Analysis $35.23 +0.23 (+0.66%) As of 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock About Sanuwave Health Stock (NASDAQ:SNWV) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Sanuwave Health alerts:Sign Up Key Stats Today's Range$34.50▼$36.0050-Day Range$26.24▼$39.2452-Week Range$5.21▼$39.83Volume38,268 shsAverage Volume52,098 shsMarket Capitalization$301.92 millionP/E RatioN/ADividend YieldN/APrice Target$49.00Consensus RatingBuy Company Overview SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia. Read More Sanuwave Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks45th Percentile Overall ScoreSNWV MarketRank™: Sanuwave Health scored higher than 45% of companies evaluated by MarketBeat, and ranked 1190th out of 1,841 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingSanuwave Health has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageSanuwave Health has only been the subject of 1 research reports in the past 90 days.Read more about Sanuwave Health's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Sanuwave Health is -7.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Sanuwave Health is -7.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for SNWV. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSanuwave Health does not currently pay a dividend.Dividend GrowthSanuwave Health does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for SNWV. News and Social Media2.6 / 5News Sentiment0.70 News SentimentSanuwave Health has a news sentiment score of 0.70. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.42 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Sanuwave Health this week, compared to 1 article on an average week. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Sanuwave Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $166,588.00 in company stock.Percentage Held by Insiders14.90% of the stock of Sanuwave Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions42.53% of the stock of Sanuwave Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Sanuwave Health's insider trading history. Receive SNWV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sanuwave Health and its competitors with MarketBeat's FREE daily newsletter. Email Address SNWV Stock News HeadlinesSanuwave Will Host a Conference Call on August 8, 2025 at 8:30 AM (ET) to Present Q2 2025 Financial ResultsAugust 4 at 5:00 PM | globenewswire.comSanuwave Health (NASDAQ:SNWV) Now Covered by Analysts at Roth CapitalJuly 30, 2025 | americanbankingnews.comTrump’s SHOCKING Plan to Create MASSIVE Wealth for AmericansJames Altucher says Donald Trump just made a move so surprising, it could go down as the most lucrative presidential decision in modern history. According to his research, this could set off a massive wealth wave—potentially turning a $900 investment into $108,000 in under a year. It has nothing to do with tariffs or trade wars—but it’s already gaining momentum, and the window to act is closing fast.August 6 at 2:00 AM | Paradigm Press (Ad)Sanuwave Health to Present at Canaccord Genuity Growth ConferenceJuly 22, 2025 | globenewswire.comSanuwave: High Growth Wound Care Tech Primed For A BreakoutJune 11, 2025 | seekingalpha.comSanuwave Health Appoints Industry Veteran Dustin Libby as Executive Vice President of Commercial OperationsJune 3, 2025 | globenewswire.comSANUWAVE Health, Inc. (SNWV): A Bull Case TheoryMay 29, 2025 | insidermonkey.comSanuwave Health Appoints Greg Bazar to Board of DirectorsMay 28, 2025 | globenewswire.comSee More Headlines SNWV Stock Analysis - Frequently Asked Questions How have SNWV shares performed this year? Sanuwave Health's stock was trading at $37.61 at the beginning of 2025. Since then, SNWV stock has decreased by 6.3% and is now trading at $35.23. How were Sanuwave Health's earnings last quarter? Sanuwave Health Inc. (NASDAQ:SNWV) released its earnings results on Friday, May, 9th. The company reported ($0.66) earnings per share for the quarter. The business earned $9.34 million during the quarter. Read the conference call transcript. Who are Sanuwave Health's major shareholders? Top institutional investors of Sanuwave Health include Evernest Financial Advisors LLC (0.29%). Insiders that own company stock include Peter Stegagno and Iulian Cioanta. View institutional ownership trends. How do I buy shares of Sanuwave Health? Shares of SNWV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings5/09/2025Today8/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED PRODUCTS Sub-IndustryMedical Equipment Current SymbolNASDAQ:SNWV Previous SymbolNASDAQ:SNWV CIK1417663 WebN/A Phone(770) 419-7525Fax770-419-8634Employees40Year FoundedN/APrice Target and Rating Average Price Target for Sanuwave Health$49.00 High Price Target$49.00 Low Price Target$49.00 Potential Upside/Downside+40.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Trailing Twelve Months)($4.56) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$31.37 million Net Margins-89.86% Pretax Margin-89.78% Return on EquityN/A Return on Assets-145.76% Debt Debt-to-Equity RatioN/A Current Ratio0.40 Quick Ratio0.28 Sales & Book Value Annual Sales$32.63 million Price / Sales9.16 Cash FlowN/A Price / Cash FlowN/A Book Value($1.49) per share Price / Book-23.42Miscellaneous Outstanding Shares8,570,000Free Float7,292,000Market Cap$299.01 million OptionableN/A Beta1.29 Social Links Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (NASDAQ:SNWV) was last updated on 8/6/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredDebt Crisis Warning: How to Protect Your Wealth Before August 31stOn August 31st, the U.S. runs out of “extraordinary measures” to avoid default—and Washington insiders are alr...American Alternative | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredGuess Who the Gvt Could Partner With Next?The Government Just Made a $400M Bet. Who's Next? A $100 trillion wealth shift is quietly underway... and t...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanuwave Health Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanuwave Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.